Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow
https://doi.org/10.24411/0235W2990W2019W10006
About the Authors
A. V. AlekhinRussian Federation
G. P. Arutyunov
Russian Federation
S. F. Bagnenko
Russian Federation
A. Zh. Bayalieva
Russian Federation
M. V. Zhuravleva
Russian Federation
A. D. Kaprin
Russian Federation
O. N. Kotenko
Russian Federation
V. V. Krylov
Russian Federation
Yu. V. Miroshnichenko
Russian Federation
I. V. Molchanov
Russian Federation
S. V. Natarov
Russian Federation
E. E. Petryaykina
Russian Federation
Yu. S. Polushin
Russian Federation
D. N. Protsenko
Russian Federation
A. A. Skopets
Russian Federation
S. V. Sidorenko
Russian Federation
A. V. Shchegolev
Russian Federation
M. Sh. Khubutia
Russian Federation
S. M. Yudin
Russian Federation
S. V. Yakovlev
Russian Federation
Review
For citations:
Alekhin A.V., Arutyunov G.P., Bagnenko S.F., Bayalieva A.Zh., Zhuravleva M.V., Kaprin A.D., Kotenko O.N., Krylov V.V., Miroshnichenko Yu.V., Molchanov I.V., Natarov S.V., Petryaykina E.E., Polushin Yu.S., Protsenko D.N., Skopets A.A., Sidorenko S.V., Shchegolev A.V., Khubutia M.Sh., Yudin S.M., Yakovlev S.V. Council of Experts Resolution on the Use of Inhibitor-Protected Beta-Lactams in the Treatment of Community-Acquired and Nosocomial Infections 11 February , 2019, Moscow. Antibiot Khimioter = Antibiotics and Chemotherapy. 2019;64(1-2):34-36. (In Russ.) https://doi.org/10.24411/0235W2990W2019W10006
Views:
310
Email this article 